0
0
Digital therapeutics are revolutionizing the way healthcare is delivered. These software-based interventions allow healthcare workers and patients to use apps or digital platforms to manage and treat a wide range of conditions, including mental health problems, chronic diseases, neurological disorders, addiction, and physical injuries.
The concept of digital therapeutics is not new, but its commercialization has accelerated in recent years. This rapid growth has been driven by the increasing adoption of smartphones and other digital devices, as well as the growing demand for remote care solutions.
However, commercializing digital therapeutics across international markets presents a unique set of challenges. Unlike traditional healthcare companies that may focus on domestic markets first, digital therapeutic firms need to consider global expansion from the outset. This is because the digital world operates on a global scale, making international markets just as accessible as domestic ones.
According to a study published in the International Journal of Technology Transfer and Commercialisation, companies that develop digital therapeutics need to adopt a strategic approach to internationalization. This includes building strong networks, fostering continuous learning within the organization, and developing flexible business models that can adapt to different regulatory and reimbursement environments.
The study’s authors, Amy Lee and Grigorij Ljubownikow of The University of Auckland, New Zealand, emphasize the importance of collaboration and networking in navigating the complex international landscape. Companies need to be able to adapt their products and business models to meet the specific needs of different markets.
Overall, digital therapeutics have the potential to transform healthcare delivery on a global scale. By overcoming the challenges of commercialization and internationalization, these innovative solutions can improve access to care and quality of life for millions of people around the world.
Sources:
- Lee, A., & Ljubownikow, G. (2025). The road to commercialisation: expanding digital therapeutics across international markets. International Journal of Technology Transfer and Commercialisation, 14(4), 382-402. [invalid URL removed]
